Please read my post , here we go again, I put it in BOLD so you will not have to read it all :
About rhinitis :
https://aacijournal.biomedcentral.com/articles/10.1186/s13223-017-0183-z
"The Phase 2 trial was the first large clinical study to assess a CRTH2 antagonist in seasonal AR in a real-life setting. Setipiprant dose-related efficacy in the Phase 2 trial
was not confirmed during Phase 3. Setipiprant was well tolerated in both studies. "
"
WAS NOT CONFIRMED DURIN PHASE 3". Do you understand what that means ? It means , it FAILED .
There is not any other kind of this drug on the Market, and Setipiprant, should be realeased at least 4 years before fevipiprant. Meaning, if that stuff really works, Allergan should do tons of money during that 4 years, after all, they spent the best part already in all the clinical trials for Asthma. Setipiprant works great in Vitro, not in vivo.
That thing of telling 2000mg vs 150mg is a none sense. Is like telling 200 mg of Finasteride is like 0.5mg of Dutasteride . That none sense it is. You can use 10 grams of seti and you will not get the results that will give Fevi.
I am not telling that Fevipiprant will work, I am telling that we had the bad luck of using a extremly weak drug to test the theory. Was a really bad luck, f*****g destinity, that was seti instead of Fevi the one used for the clinical trials on Androgenetic Alopecia.